B. Braun Launches Introcan Safety 2 IV Catheter With Multi-Access Blood Control Designed to Protect Clinicians Every Time the Hub Is Accessed
B. Braun Launches Introcan Safety 2 IV Catheter With Multi-Access Blood Control Designed to Protect Clinicians Every Time the Hub Is Accessed
BETHLEHEM, Pa., Oct. 11, 2023 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy, announced today the launch of its new Introcan Safety 2 IV Catheter with Multi-Access Blood Control. The Introcan Safety 2 IV Catheter is the latest development from B. Braun in a long line of passive needlestick prevention catheters. In addition to automatic needlestick protection, clinicians are protected from blood exposure by a blood control feature every time the hub is accessed1 – reducing the risk of bloodborne pathogen exposure throughout the IV process.
賓夕法尼亞州伯利恒， 2023 年 10 月 11 日 /PRNewswire/ — 智能輸液療法領域的領導者 B. Braun Medical Inc.（B. Braun）今天宣佈推出其全新 Introcan Safety 2 個帶多通道血液控制功能的靜脈注射導管。Introcan Safety 2 IV 導管是 B. Braun 在一系列被動式針刺預防導管中最新開發的產品。除了自動針刺保護外，每次使用針刺中心時，都可通過血液控制功能保護臨床醫生免受血液暴露1 — 降低在整個靜脈注射過程中血源性病原體暴露的風險。
IV access is a critical element of infusion therapy, and needlestick injuries continue to be a serious risk faced by clinicians in their daily routines, potentially exposing them to bloodborne pathogens.2 Studies show that passive, fully automatic safety devices prevent needlestick injuries two times better than a semi-automatic "push button" safety shield and three times better than a manually sliding shield.3 With the Introcan Safety 2 Catheter, clinicians are protected by a truly automatic passive safety device.
靜脈注射是輸液治療的關鍵要素，針刺損傷仍然是臨床醫生在日常生活中面臨的嚴重風險，有可能使他們接觸血液傳播的病原體。2 研究表明，被動的全自動安全設備防止針刺傷害的效果是半自動 “按鈕” 安全防護罩的兩倍，是手動滑動防護罩的三倍。3 使用 Introcan Safety 2 導管，臨床醫生可以受到真正的自動被動安全裝置的保護。
In addition to needlestick injuries, mucocutaneous blood exposure due to blood spillage from the catheter hub is also a concern. Blood control IV catheters have been shown to significantly reduce the risk of blood exposure and the workload associated with cleaning.5 In addition, results of a survey point to a potential reduction of costs associated with blood cleanup time and materials.4 With the new Introcan Safety 2 Catheter, the multi-access blood control feature works multiple times, helping to reduce blood exposure and spillage throughout the IV process.
除了針刺損傷外，由於導管中心溢出血液而導致的皮膚粘膜血液暴露也是一個問題。血液控制靜脈導管已被證明可以顯著降低血液暴露風險和與清潔相關的工作量。5 此外，調查結果表明，與血液清理時間和材料相關的成本可能會降低。4 使用全新 Introcan Safety 2 導管，多通道血液控制功能可多次起作用，有助於減少整個靜脈注射過程中的血液暴露和溢出。
"Appropriate device selection is key to achieving successful PIVC outcomes," said Chad Laity, Director of Marketing, Vascular Access, IV Systems and Securement. "The newly launched Introcan Safety 2 IV Catheter with Multi-Access Blood Control provides clinicians with another option when choosing the right device for their patients. When combined with our Peripheral Advantage Program, our technology and solutions are designed to facilitate the best possible outcomes around vascular access care."
他說：“適當的設備選擇是成功實現PIVC結果的關鍵。” Chad Laity，市場營銷、血管通路、靜脈注射系統和安全總監。“新推出的帶有多通道血液控制功能的Introcan Safety 2 IV導管爲臨床醫生在爲患者選擇合適的設備時提供了另一種選擇。與我們的外周優勢計劃相結合，我們的技術和解決方案旨在促進血管通路護理取得最佳結果。”
For more information on our portfolio of products that seamlessly work to help advance patient and clinician safety and care success, visit .
有關我們的產品組合的更多信息，這些產品組合可以無縫地幫助提高患者和臨床醫生的安全和護理成功，請訪問。
About B. Braun
關於 B. Braun
B. Braun Medical Inc. (B. Braun) is a leader in smart infusion therapy and safe and effective pharmacy products, patient and provider safety, and sustainable health solutions. Our purpose is to help providers constantly improve patient satisfaction and outcomes. With products and services created to help healthcare professionals focus on what matters most—their patients—we're uniquely positioned to help health systems succeed now and in the future. B. Braun is headquartered in Bethlehem, Pennsylvania and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap and CAPS. The company employs 8,500 people at over 30 locations across North America.
B. Braun Medical Inc.（B. Braun）是智能輸液療法和安全有效的藥房產品、患者和提供者安全以及可持續健康解決方案領域的領導者。我們的目的是幫助醫療服務提供者不斷提高患者滿意度和治療效果。我們的產品和服務旨在幫助醫療保健專業人員專注於最重要的事情——他們的患者，我們處於獨特的地位，可以幫助醫療系統在現在和將來取得成功。B. Braun 的總部位於 賓夕法尼亞州伯利恒 也是美國 B. Braun 集團公司的一部分，該集團包括 B. Braun 介入系統、Aesculap 和 CAPS。該公司在全球 30 多個地點擁有 8,500 名員工 北美。
Globally, the B. Braun Group of Companies employs more than 64,000 employees in 64 countries. Guided by its Sharing Expertise philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, explore our website.
在全球範圍內，博朗集團在64個國家擁有超過64,000名員工。以其共享專業知識爲指導 理念，B. Braun 不斷與客戶、合作伙伴和臨床醫生交流知識，以解決改善護理和降低成本的關鍵問題。要了解有關 B. Braun Medical 的更多信息，請瀏覽我們的網站。
SOURCE B. Braun Medical Inc.
來源 B. Braun Medical Inc.
譯文內容由第三人軟體翻譯。